CDC Website CDC Website

To Join the NPIN community or

Home » Rural Communities Opioid Response Program – Neonatal Abstinence Syndrome (RCORP-NAS)

Due to the evolving COVID-19 situation, NPIN may not have the most up-to-date organization changes to services or hours. Please call the organization or visit their website to find out about any changes. This site does not have information about where to get tested for COVID-19. For COVID-19 information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Debido a la rápida evolución de la situación con respecto al COVID-19, NPIN podría no tener la información mas actualizada de los servicios u horas de las organizaciones. Por favor llame o visite la página web de la organización para conocer los cambios. Este sitio no tiene información sobre donde hacerse la prueba del COVID-19. Para información sobre el COVID-19 por favor visite: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Rural Communities Opioid Response Program – Neonatal Abstinence Syndrome (RCORP-NAS)

he Rural Communities Opioid Response Program (RCORP) is a Health Resources and Services Administration (HRSA) multi-year initiative aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in high-risk, rural communities. This notice announces the opportunity to apply for funding under RCORP-Neonatal Abstinence Syndrome (RCORP-NAS). The purpose of the RCORP- NAS project is to advance RCORP’s overall goal and reduce the incidence and impact of Neonatal Abstinence Syndrome (NAS) in rural communities by improving systems of care, family supports, and social determinants of health. In 2017, the U.S. Department of Health and Human Services (HHS) published a five-point Strategy to Combat Opioid Abuse, Misuse, and Overdose, to outline concrete steps that local communities can take to address the opioid epidemic. In alignment with the HHS Five-Point Strategy, and as part of the RCORP initiative, RCORP- NAS award recipients will implement a set of SUD/OUD Prevention, Treatment, and Recovery Strategies as outlined in Section IV.2. These strategies are grounded in evidence-based or promising practice models. Applicants are encouraged to select the strategies that best address the needs identified in their respective service areas and target populations. The Target Population for this grant is pregnant women, mothers, and women of childbearing age who have a history of, or who are at risk for, SUD/OUD and their children, families, and caregivers who reside in HRSA-designated rural areas, as defined by the Rural Health Grants Eligibility Analyzer. Given the complex and multifaceted nature of SUD/OUD and NAS, as well as the need to secure community buy-in and social services support, HRSA requires that RCORP-NAS applicants operate within a broad, multi-sectoral consortium, as outlined in Section III.1. Consortia should be able to operationalize their proposed work plans immediately upon receipt of award. The primary focus of this grant is to reduce incidence of NAS and OUD by improving local conditions and creating systems change. However, recognizing that many individuals with OUD have co-occurring substance use disorders, consortia may also choose to address additional substances of concern in the target population. . Please note that no competitive advantage, funding priority, or preference is associated with proposing activities that address other SUD-related needs, including those related to methamphetamine or alcohol.

Application Due Date
7/22/20
Project Start Date
9/30/20
Application Contact
James
Padgett
Grants Management Specialist
5600 Fishers Lane
Mailstop 10N108B
Rockville
20857
MD
301-443-0207
jpadgett@hrsa.gov
Technical Contact
Monica
Rousseau
Public Health Analyst
5600 Fishers Lane
Room 10W57A
Rockville
20857
MD
ruralopioidresponse@hrsa.gov
301-945-0928
Fund Duration
Three years.
Subjects
Audiences

Fund Number: 

347024

Fund ID: 

HRSA-20-106

Last modified: 

6/24/20